Connect Biopharma Holdings Limited Increase (Decrease) in Prepaid Expense and Other Assets
Connect Biopharma Holdings Limited (CNTB) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$2.12M, a 194.63% decline year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$257.00K, a 119.95% decline year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.23M.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.81M, a 76.17% increase year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for fiscal 2025 was $4.11M.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.79M.
- Connect Biopharma Holdings Limited increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$3.69M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.37M 10-Q · filed 2026-08-12 | -$3.60M derived: sum of 3 quarters · filed 2026-08-12 | -$1.79M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$257.00K 10-Q · filed 2026-05-12 | -$1.48M derived: sum of 2 quarters · filed 2026-05-12 | $329.00K derived: sum of 3 quarters · filed 2026-05-12 | $2.56M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $586.00K derived: sum of 2 quarters · filed 2026-03-31 | $2.82M derived: sum of 3 quarters · filed 2026-08-12 | $4.11M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.05M derived: sum of 2 quarters · filed 2026-08-12 | $5.33M 10-Q · filed 2025-11-12 | $3.77M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.52M 10-Q · filed 2026-08-12 | $1.96M derived: sum of 3 quarters · filed 2026-08-12 | $2.99M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.29M 10-Q · filed 2026-05-12 | -$275.00K derived: sum of 2 quarters · filed 2026-05-12 | $753.00K derived: sum of 3 quarters · filed 2026-05-12 | $711.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$535.00K derived: sum of 2 quarters · filed 2026-03-31 | -$577.00K derived: sum of 3 quarters · filed 2026-03-31 | -$1.79M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $986.00K derived: sum of 2 quarters · filed 2025-11-12 | -$223.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.25M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.21M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$3.69M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |